UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 249

Sortiert nach

A Novel Channelopathy in Pulmonary Arterial Hypertension

The New England journal of medicine, 2013-07, Vol.369 (4), p.351-361

2013

Volltextzugriff (PDF)

GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis

Journal of thrombosis and haemostasis, 2021-10, Vol.19 (10), p.2612-2617

2021

Volltextzugriff (PDF)

Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study

Journal of the American Heart Association, 2019-08, Vol.8 (15), p.e012994-e012994

2019

Volltextzugriff (PDF)

Addressing unmeasured confounders in cohort studies: Instrumental variable method for a time‐fixed exposure on an outcome trajectory

Biometrical journal, 2024-01, Vol.66 (1), p.e2200358-n/a

2024

Volltextzugriff (PDF)

Anti-integrin α v therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1 + stromal cells

Scientific reports, 2020-07, Vol.10 (1), p.11404-11404, Article 11404

2020

Volltextzugriff (PDF)

Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project

British journal of haematology, 2012-04, Vol.157 (2), p.230-239

2012

Volltextzugriff (PDF)

Testing for association with rare variants in the coding and non-coding genome: RAVA-FIRST, a new approach based on CADD deleteriousness score

PLoS genetics, 2022-09, Vol.18 (9), p.e1009923-e1009923

2022

Volltextzugriff (PDF)

A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process

Journal of thrombosis and haemostasis, 2019-11, Vol.17 (11), p.1808-1814

2019

Volltextzugriff (PDF)

Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells

Journal of the American College of Cardiology, 2017-08, Vol.70 (6), p.728-741

2017

Volltextzugriff (PDF)

EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

Nature genetics, 2014-01, Vol.46 (1), p.65-69

2014

Volltextzugriff (PDF)

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

British journal of haematology, 2018-02, Vol.180 (3), p.335-345

2018

Volltextzugriff (PDF)

Genetics of Venous Thrombosis: update in 2015

Thrombosis and haemostasis, 2015-11, Vol.114 (5), p.910

2015

Volltextzugriff (PDF)

Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders

Cardiovascular research, 2023-07, Vol.119 (8), p.1624-1640

2023

Volltextzugriff (PDF)

DNA-pools targeted-sequencing as a robust cost-effective method to detect rare variants: Application to dilated cardiomyopathy genetic diagnosis

Clinical genetics, 2024-02, Vol.105 (2), p.185-189

2024

Volltextzugriff (PDF)

Targeted panel sequencing in adult patients with left ventricular non‐compaction reveals a large genetic heterogeneity

Clinical genetics, 2019-03, Vol.95 (3), p.356-367

2019

Volltextzugriff (PDF)

Removing Batch Effects from Longitudinal Gene Expression - Quantile Normalization Plus ComBat as Best Approach for Microarray Transcriptome Data

PloS one, 2016-06, Vol.11 (6), p.e0156594-e0156594

2016

Volltextzugriff (PDF)

Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies

American journal of human genetics, 2014-05, Vol.94 (5), p.662-676

2014

Volltextzugriff (PDF)

Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?

Journal of thrombosis and haemostasis, 2024-07, Vol.22 (7), p.1826-1834

2024

Volltextzugriff (PDF)

Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States

PLoS genetics, 2017-09, Vol.13 (9), p.e1007040-e1007040

2017

Volltextzugriff (PDF)

Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci

Nature communications, 2015-02, Vol.6 (1), p.6326-6326, Article 6326

2015

Volltextzugriff (PDF)

A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling

American journal of human genetics, 2020-08, Vol.107 (2), p.211-221

2020

Volltextzugriff (PDF)

APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

Haematologica (Roma), 2023-03, Vol.108 (3), p.772

2023

Volltextzugriff (PDF)

Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning

American journal of respiratory and critical care medicine, 2021-04, Vol.203 (8), p.1006-1022

2021

Volltextzugriff (PDF)

Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2556-2564

2010

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(221)

Publikationsform

Artikel
(247)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(15)
Plos One
(15)
American Journal Of Human Genetics
(11)
Journal Of Thrombosis And Haemostasis
(11)
Plos Genetics
(8)
Circulation
(7)
Journal Of The American College Of Cardiology
(7)
Nature Genetics
(7)
Diabetes
(6)
Human Molecular Genetics
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A Novel Channelopathy in Pulmonary Arterial Hypertension

GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis

Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study

DNA methylation and body-mass index: a genome-wide analysis

Addressing unmeasured confounders in cohort studies: Instrumental variable method for a time‐fixed exposure on an outcome trajectory

Anti-integrin α v therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1 + stromal cells

Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project

Testing for association with rare variants in the coding and non-coding genome: RAVA-FIRST, a new approach based on CADD deleteriousness score

A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process

Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells

EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

Genetics of Venous Thrombosis: update in 2015

Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders

DNA-pools targeted-sequencing as a robust cost-effective method to detect rare variants: Application to dilated cardiomyopathy genetic diagnosis

Targeted panel sequencing in adult patients with left ventricular non‐compaction reveals a large genetic heterogeneity

Removing Batch Effects from Longitudinal Gene Expression - Quantile Normalization Plus ComBat as Best Approach for Microarray Transcriptome Data

Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies

Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?

Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States

Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci

A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling

APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning

Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

Suchergebnisse filtern